PETV News & Events

PetVivo, in cooperation with its wholly owned subsidiaries PetVivo Animal Health and PetVivo AI announced the launch of PetVivo.ai, a new artificial intelligence platform delivering a customer acquisition cost of $42.53-a 50-89% reduction compared to the $80-$400 typically spent by veterinary practices. The platform generates qualified leads for $3 per pet parent and uses automated AI engagement to convert these leads into paying customers.

Reports Q2 revenue $303k vs 201k last year. "Our strong growth for the quarter demonstrates the success of our overall strategy for driving greater adoption of our flagship animal osteoarthritis veterinary medical device, Spryng with OsteoCushion Technology," commented PetVivo CEO, John Lai. "This record performance for a second fiscal quarter also reflects the increasing awareness of PrecisePRP(TM) for the treatment of osteoarthritis in animals that can be administered alongside Spryng."

PetVivo Holdings announced that Josh Ruben has joined the Company's Board of Directors. Ruben is the Managing Director of Life Sciences at Trinity Capital where he focuses on venture lending to healthcare companies.